| Lissa Woodruff, MD | |
|
3219 Central Ave, Kearney, NE 68847-2949 | |
| (308) 865-2808 | |
| Not Available |
| Full Name | Lissa Woodruff |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 31 Years |
| Location | 3219 Central Ave, Kearney, Nebraska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154304301 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 19918 (Nebraska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chi Health Good Samaritan | Kearney, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Chi Health Clinic Specialty Llc | 4789098443 | 234 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
According to The Denver Post, Colorado's marketplace is seeing an acceleration in the rate of enrollment while the Los Angeles Times highlights specific outreach efforts as the clock ticks toward March 31. In Oregon, though, the countdown is on for the release of a report detailing what went wrong. And, in Connecticut, GOP state legislators want to know any of the consumers using the state's online portal were previously uninsured.
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Thanks in part to studies that follow subjects for a long time, psychologists are learning more about differences between people. In a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science, the author describes how psychologists can use their data to learn about the different ways that people's minds work.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 1 days ago
| Entity Name | The Physician Network |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
According to The Denver Post, Colorado's marketplace is seeing an acceleration in the rate of enrollment while the Los Angeles Times highlights specific outreach efforts as the clock ticks toward March 31. In Oregon, though, the countdown is on for the release of a report detailing what went wrong. And, in Connecticut, GOP state legislators want to know any of the consumers using the state's online portal were previously uninsured.
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Thanks in part to studies that follow subjects for a long time, psychologists are learning more about differences between people. In a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science, the author describes how psychologists can use their data to learn about the different ways that people's minds work.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 1 days ago
| Entity Name | Chi Health Clinic Specialty Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
According to The Denver Post, Colorado's marketplace is seeing an acceleration in the rate of enrollment while the Los Angeles Times highlights specific outreach efforts as the clock ticks toward March 31. In Oregon, though, the countdown is on for the release of a report detailing what went wrong. And, in Connecticut, GOP state legislators want to know any of the consumers using the state's online portal were previously uninsured.
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Thanks in part to studies that follow subjects for a long time, psychologists are learning more about differences between people. In a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science, the author describes how psychologists can use their data to learn about the different ways that people's minds work.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lissa Woodruff, MD 10 E 31st St, Kearney, NE 68847-2908 Ph: (308) 865-2808 | Lissa Woodruff, MD 3219 Central Ave, Kearney, NE 68847-2949 Ph: (308) 865-2808 |
News Archive
Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.
According to The Denver Post, Colorado's marketplace is seeing an acceleration in the rate of enrollment while the Los Angeles Times highlights specific outreach efforts as the clock ticks toward March 31. In Oregon, though, the countdown is on for the release of a report detailing what went wrong. And, in Connecticut, GOP state legislators want to know any of the consumers using the state's online portal were previously uninsured.
Today's headlines include reports about how the day-after debate about the Congressional Budget Office's updated health law projections played out on Capitol Hill.
Thanks in part to studies that follow subjects for a long time, psychologists are learning more about differences between people. In a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science, the author describes how psychologists can use their data to learn about the different ways that people's minds work.
The biopharmaceutical company Antisense Pharma GmbH has announced today that it has received the approval by Health Canada for its pivotal Phase III clinical trial SAPPHIRE in patients with recurrent or refractory anaplastic astrocytoma.
› Verified 1 days ago
Ronald Dobesh, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-2808 | |
Dr. John S Waters, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 E 31st St, Kearney, NE 68847 Phone: 308-865-7100 | |
Dr. Panayotis-alain Efstratiou, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 201, Kearney, NE 68847 Phone: 308-865-7271 | |
Dr. Meenakshi Ghosh, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave Ste 200, Kearney, NE 68847 Phone: 308-865-2370 | |
Dr. Anub George John, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3219 Central Ave, Kearney, NE 68847 Phone: 308-865-7271 Fax: 308-865-2045 | |
Scott Smith, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 816 22nd Ave, Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |